undamentalytics Newsletter
Sign in

Benitec Biopharma Inc. balance sheet

At the end of fiscal 2024, Benitec Biopharma Inc. had total assets of $52.2m, total liabilities of $5.0m and shareholders' equity of $47.2m. It held $50.9m in cash against $0 of debt: net cash of $50.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 2024LTMMar 2025
Cash and equivalents1610204251104
Receivables3000000
Total current assets1911215452104
Total assets1912216452105
Total current liabilities3113457
Total debt0000000
Total liabilities3113458
Shareholders' equity171020304798
Net debt (negative = net cash)−16−10−20−4−2−51−104
Shares outstanding——65m—67m20m26m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Benitec Biopharma Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Benitec Biopharma Inc.